亨利希恩
HSIC
86.38
-0.61
-0.70%
亨利希恩
US · HSIC
#1526 按市值排名
上市于 1970
86.38
-0.61
-0.70%
实时 - 追踪5344个代码 - 心跳于388秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例上升了0.4个百分点。
机构持股
- 机构持股比例
- 114.88% +0.37pp
- 机构数量
- 667 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund78.36%
VC/PE Fund14.71%
Hedge Fund11.09%
Public Company4.60%
Private Company3.35%
Individual/Insider1.19%
Sovereign Wealth Fund1.12%
Government Pension Fund0.99%
Insurance Company0.37%
主要股东 截至 2026-06-30
KKR & Co. Inc.
14.04% · 15.65M 股
BlackRock
6.30% · 7.02M 股
Vanguard Capital Management, LLC
6.18% · 6.89M 股
FMR
6.09% · 6.79M 股
Artisan Partners Limited Partnership
5.80% · 6.47M 股
State Street Global Advisors
3.86% · 4.31M 股
Vanguard Portfolio Management, LLC
3.71% · 4.13M 股
J.P. Morgan Asset Management, Inc.
3.39% · 3.77M 股
American Century Investment Management
3.10% · 3.46M 股
Dimensional Fund Advisors
3.05% · 3.39M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 25次买入 · 22次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| KKR & Co. Inc. | -- | 14.04% |
| Stanley Bergman | Executive Chairperson | 0.58% |
| James Breslawski | Executive Vice Chairman & President | 0.14% |
| Andrea Albertini | Chief Executive Officer of International Distribution Group | 0.10% |
| Tom Popeck | Chief Executive Officer of Healthcare Specialties Group | 0.08% |
| Bradford Connett | Chief Executive Officer of North America Distribution Group | 0.06% |
| Walter Siegel | Chief Legal Officer | 0.04% |
| Carol Raphael | Independent Director | 0.03% |
| Joseph Herring | Independent Director | 0.02% |
| Michael Ettinger | Chief Operating Officer | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-07 | Andrea Albertini | Chief Executive Officer of International Distribution Group | Sale to Issuer | -4,587 | $88.86 |
| 2026-06-29 | Joseph Herring | Independent Director | Intent to Sell (Form 144) | -28,791 | $84.29 |
| 2026-06-11 | William Daniel | Independent Director | Other Acquisition | +2,215 | -- |
| 2026-05-25 | Stanley Bergman | Executive Chairperson | Other Disposition | -50 | -- |
| 2026-05-20 | Kelly Murphy | General Counsel | Initial Statement of Beneficial | 0 | -- |
| 2026-05-18 | Stanley Bergman | Executive Chairperson | Other Disposition | -1,040 | -- |
| 2026-05-10 | William Daniel | Independent Director | Open Market Acquisition | +10,000 | $69.19 |
| 2026-03-18 | Tom Popeck | Chief Executive Officer of Healthcare Specialties Group | Open Market Disposition | -1,355 | $72.79 |
| 2026-03-16 | Michael Ettinger | Chief Operating Officer | Other Disposition | -2,300 | -- |
| 2026-03-15 | Stanley Bergman | Executive Chairperson | Sale to Issuer | -50 | $74.61 |
| 2026-03-15 | Stanley Bergman | Executive Chairperson | Other Disposition | -400 | -- |
| 2026-03-15 | Mark Mlotek | Executive VP, Chief Strategic Officer & Executive Director | Sale to Issuer | -5,928 | $74.61 |
| 2026-03-15 | Michael Ettinger | Chief Operating Officer | Sale to Issuer | -4,214 | $74.61 |
| 2026-03-15 | Ronald South | Senior Vice President | Sale to Issuer | -5,216 | $74.61 |
| 2026-03-15 | Andrea Albertini | Chief Executive Officer of International Distribution Group | Sale to Issuer | -1,401 | $74.61 |
| 2026-03-15 | Tom Popeck | Chief Executive Officer of Healthcare Specialties Group | Sale to Issuer | -587 | $74.61 |
| 2026-03-15 | Christine Sheehy | Chief Human Resources Officer | Sale to Issuer | -463 | $74.61 |
| 2026-03-11 | Stanley Bergman | Executive Chairperson | Other Disposition | -970 | -- |
| 2026-03-09 | Kurt Kuehn | Independent Director | Open Market Disposition | -2,844 | $78.96 |
| 2026-03-05 | Henry Kravis | -- | Other Derivative Acquisition | +918,723 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
亨利希恩 讨论区 0 条评论